Tag: Pain-Relieving Drugs

Drug Giants Pursuing $50 Billion Settlement of Opioid Cases

CLEVELAND — As a critical trial deadline bears down, lawyers for states and the three largest drug distributors in the country, along with two manufacturers, have agreed on a framework for a deal to resolve thousands of opioid cases with a settlement worth nearly $50 billion in cash and addiction treatments. Three people familiar with […]

Read More

D.E.A. Let Opioid Production Surge as Crisis Grew, Inspector General Says

The Drug Enforcement Administration authorized large increases in the production of painkillers even as the number of opioid-related deaths in the United States soared, the Justice Department’s inspector general said in a harsh review on Tuesday. The watchdog office said that the D.E.A. was “slow to respond” to the opioid crisis, adding that more than […]

Read More

Sacklers vs. States: Settlement Talks Stumble Over Foreign Business

Purdue Pharma’s negotiations to settle thousands of lawsuits over the company’s role in the opioids crisis have turned into a standoff between members of the Sackler family, who own the company, and a group of state attorneys general over how much the family should pay and whether it can continue selling drugs abroad. The Sacklers […]

Read More

Sacklers Would Give Up Ownership of Purdue Pharma Under Settlement Proposal

The Sackler family would give up ownership of Purdue Pharma, the company blamed for much of the opioid epidemic, and pay $3 billion of their own money under terms of a settlement proposal to resolve thousands of federal and state lawsuits, according to a person familiar with the negotiations. The discussions have been going on […]

Read More

Johnson & Johnson’s Brand Falters Over Its Role in the Opioid Crisis

In the 1980s, Johnson & Johnson needed a reliable supply of opium for a popular product, Tylenol with codeine. So the health care conglomerate, better known for baby shampoo and Band-Aids, bought a business that grew and processed opium poppies in faraway Tasmania, off the coast of Australia. By 2015, at the height of the […]

Read More

Johnson & Johnson Ordered to Pay $572 Million in Landmark Opioid Trial

A judge in Oklahoma on Monday ruled against Johnson & Johnson, the deep-pocketed corporate giant, and ordered it to pay the state $572 million in the first trial of an opioid manufacturer for the destruction wrought by prescription painkillers. Johnson & Johnson, which contracted with poppy growers in Tasmania, supplied 60 percent of the opiate […]

Read More

A Nun, a Doctor and a Lawyer — and Deep Regret Over the Nation’s Handling of Opioids

PENNINGTON GAP, Va. — Years before there was an opioid epidemic in America, Sister Beth Davies knew it was coming. In the late 1990s, patient after patient addicted to a new prescription painkiller called OxyContin began walking into the substance abuse clinic she ran in this worn Appalachian town. A local physician, Dr. Art Van […]

Read More

New York Subpoenas Banks, Financial Advisers for Sackler Records

The New York state attorney general has begun issuing subpoenas to 33 financial institutions and investment advisers with ties to the Sackler family, part of an aggressive effort to track billions of dollars that prosecutors claim the family siphoned out of Purdue Pharma to hide profits gained from the company’s opioid painkillers. The recipients of […]

Read More

Can Marijuana Help Cure the Opioid Crisis?

The idea that legal cannabis can help address the opioid crisis has generated much hope and enthusiasm. Opioid misuse has declined in recent years at the same time that cannabis use has been increasing, with many states liberalizing marijuana laws. Based on recent research, some advocates have been promoting this connection, arguing that easier access […]

Read More

Insys, the Opioid Drug Maker, Files for Bankruptcy

The opioid manufacturer Insys Therapeutics filed for bankruptcy protection Monday, days after agreeing to pay $225 million to settle a federal investigation into the marketing practices for its powerful fentanyl painkiller. The company said it would continue operating while it comes up with a plan to pay its creditors, including the Justice Department, under Chapter […]

Read More